Diagnostic and societal impact of implementing the syncope guidelines of the European Society of Cardiology (SYNERGY study)

Table 3 Syncope-related healthcare costs per group

	Usual care (n = 275)		Syncope guidelines (n = 246)		Difference
	Number per patient	Costs per patient	Number per patient	Costs per patient	Costs per patient	p-value
Hospital admissions (days)
Following the initial ED visit*	1.36	727	1.11	591	− 136	0.23
Later	0.91	485	0.74	397	− 88	0.47
Later ED visits	0.16	45	0.15	44	− 1	0.96
Hospital diagnostic procedures	3.35	583	3.08	536	− 47	0.70
Outpatient hospital visits	0.88	94	0.72	78	− 16	0.23
Hospital treatments	0.25	409	0.18	323	− 86	0.64
GP visits	0.71	29	0.96	39	10	0.13
GP diagnostic procedures	0.38	21	0.46	27	6	0.56
Total healthcare costs (SD)		2393 (3844)		2035 (3353)	− 358	0.27
Absenteeism (days)	5.39	1152	2.62	602	− 550	0.06
Total societal costs (SD)		3545 (5170)		2637 (4109)	− 908	0.04

Average syncope-related healthcare use, absenteeism and costs (in €) per patient, by study group (usual care, n = 275; syncope guidelines, n = 246)

ISSN: 1741-7015